SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:gup.ub.gu.se/290415"
 

Sökning: onr:"swepub:oai:gup.ub.gu.se/290415" > Digoxin is associat...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00004785naa a2200949 4500
001oai:gup.ub.gu.se/290415
003SwePub
008240528s2020 | |||||||||||000 ||eng|
024a https://gup.ub.gu.se/publication/2904152 URI
024a https://doi.org/10.1002/ehf2.125392 DOI
040 a (SwePub)gu
041 a eng
042 9 SwePub
072 7a ref2 swepub-contenttype
072 7a art2 swepub-publicationtype
100a Zhou, J. M.4 aut
2451 0a Digoxin is associated with worse outcomes in patients with heart failure with reduced ejection fraction
264 c 2020-01-29
264 1b Wiley,c 2020
520 a Aims The aim of this study was to investigate the impact of digoxin use on the outcomes of patients with heart failure with reduced ejection fraction (HFrEF) and its possible interaction with atrial fibrillation or use of currently guideline-recommended treatments in the real world in China. Methods and results Patients hospitalized with HFrEF from 45 hospitals participating in the China National Heart Failure Registration Study (CN-HF) were enrolled to assess the all-cause mortality, HF mortality, all-cause re-hospitalization, and HF re-hospitalization associated with digoxin use. Eight hundred eighty-two eligible HFrEF patients in the CN-HF registry were included: 372 patients with digoxin and 510 patients without digoxin. Among them, 794 (90.0%) patients were followed up for the endpoint events, with a median follow-up of 28.6 months. Kaplan-Meier survival analysis showed that the all-cause mortality (P < 0.001) and all-cause re-hospitalization (P = 0.020) were significantly higher in digoxin group than non-digoxin group, while HF mortality (P = 0.232) and HF re-hospitalization (P = 0.098) were similar between the two groups. The adjusted Cox proportional-hazards regression analysis demonstrated that digoxin use remained as an independent risk factor for increased all-cause mortality [hazard ratio (HR) 1.76; 95% confidence interval (CI) 1.27-2.44; P = 0.001] and all-cause re-hospitalization (HR 1.27; 95% CI 1.03-1.57; P = 0.029) in HFrEF patients and the predictive value of digoxin for all-cause mortality irrespective of rhythm or in combination with other guideline-recommended therapies. Conclusions Digoxin use is independently associated with increased risk of all-cause mortality and all-cause re-hospitalization in HFrEF patients.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng
653 a Digoxin
653 a Heart failure
653 a Atrial fibrillation
653 a Prognosis
653 a clinical characteristics
653 a mortality
653 a risk
653 a guidelines
653 a withdrawal
653 a trial
653 a Cardiovascular System & Cardiology
700a Cao, J.4 aut
700a Jin, X. J.4 aut
700a Zhou, J.4 aut
700a Chen, Z. Y.4 aut
700a Xu, D. L.4 aut
700a Yang, X. C.4 aut
700a Dong, W.4 aut
700a Li, L. W.4 aut
700a Fan, Y. Y.4 aut
700a Chen, L.4 aut
700a Zhong, Q. Q.4 aut
700a Fu, Michael,d 1963u Gothenburg University,Göteborgs universitet,Institutionen för medicin,Institute of Medicine4 aut0 (Swepub:gu)xfumiw
700a Hu, K.4 aut
700a Ge, J. B.4 aut
700a Lu, Y. M.4 aut
700a Zhang, G. H.4 aut
700a Li, Chen4 aut
700a Gu, H. M.4 aut
700a Wei, M.4 aut
700a Chen, L. L.4 aut
700a Wang, J.4 aut
700a Yang, Z. Y.4 aut
700a Jin, H. G.4 aut
700a Li, X. L.4 aut
700a Qiao, Z. Y.4 aut
700a Yang, Y. J.4 aut
700a Zhao, Y. L.4 aut
700a Jia, R.4 aut
700a Hong, B.4 aut
700a Yuan, F.4 aut
700a Wang, J. F.4 aut
700a Ma, J.4 aut
700a Xu, Y.4 aut
700a Wahafu, M.4 aut
700a Yu, Q.4 aut
700a Wang, C. Q.4 aut
700a Ruan, C. W.4 aut
700a Fu, H. G.4 aut
700a Liu, X. B.4 aut
700a Xu, X.4 aut
700a Chen, S. P.4 aut
700a Liu, Q. L.4 aut
700a Shi, B.4 aut
700a Xu, J. H.4 aut
710a Göteborgs universitetb Institutionen för medicin4 org
773t Esc Heart Failured : Wileyg 7:1, s. 139-147q 7:1<139-147x 2055-5822
856u https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ehf2.12539
8564 8u https://gup.ub.gu.se/publication/290415
8564 8u https://doi.org/10.1002/ehf2.12539

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy